NMGVQGAFEZIRJL-SFTDATJTSA-N
C28H30F3N7O4 — CID 121351866
Data last refreshed: (MolForge compound catalog, from PubChem)
About NMGVQGAFEZIRJL-SFTDATJTSA-N
NMGVQGAFEZIRJL-SFTDATJTSA-N (PubChem CID 121351866) has the molecular formula C28H30F3N7O4 and a molecular weight of 585.59 g/mol. Its IUPAC name is (9S)-N-[2-[[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methoxy]pyrimidin-5-yl]-3-methyl-5-[3-(trifluoromethyl)phenyl]-1,4,6,8-tetrazatricyclo[7.3.1.02,7]trideca-2,4,6-triene-8-carboxamide.
Molecular Properties
| Compound Name | NMGVQGAFEZIRJL-SFTDATJTSA-N |
|---|---|
| PubChem CID | 121351866 |
| Molecular Formula | C28H30F3N7O4 |
| Molecular Weight | 585.59 g/mol |
| Exact Mass | 585.23 |
| IUPAC Name | (9S)-N-[2-[[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methoxy]pyrimidin-5-yl]-3-methyl-5-[3-(trifluoromethyl)phenyl]-1,4,6,8-tetrazatricyclo[7.3.1.02,7]trideca-2,4,6-triene-8-carboxamide |
| SMILES | Cc1nc(-c2cccc(C(F)(F)F)c2)nc2c1N1CCC[C@@H](C1)N2C(=O)Nc1cnc(OC[C@H]2COC(C)(C)O2)nc1 |
| InChI | InChI=1S/C28H30F3N7O4/c1-16-22-24(36-23(34-16)17-6-4-7-18(10-17)28(29,30)31)38(20-8-5-9-37(22)13-20)26(39)35-19-11-32-25(33-12-19)40-14-21-15-41-27(2,3)42-21/h4,6-7,10-12,20-21H,5,8-9,13-15H2,1-3H3,(H,35,39)/t20-,21-/m0/s1 |
| InChIKey | NMGVQGAFEZIRJL-SFTDATJTSA-N |
| XLogP | 4.81 |
| TPSA | 114.83 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 42 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 585.59 |
| LogP ≤ 5 | 4.81 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 121351866 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.